Business Investment Opportunities

We started our business 2 years ago. - Have already covered 50 percent of the Guwahati cab market. - More than 6,000 drivers are attached to our platform. - We receive around 1 lakh bookings monthly. - Charge a commission of 15% on bookings.

We started our business 2 years ago. - Have already covered 50 percent of the Guwahati cab market. - More than 6,000 drivers are attached to our platform. - We receive around 1 lakh bookings monthly. - Charge a commission of 15% on bookings.

Our business is engaged in the manufacturing of carton boxes for various companies. - We have tied up with 5 to 6 mills in the radius of 100 kms for the raw material. - On average, we have a production capacity of 4.5 ton of carton boxes per day. - Our business has 8 regular clients which use the boxes for shrimp export, egg export and spinning mills. - We have 8 permanent employees and 20 to 25 daily wage workers. - One of the leading industries, nowadays e-marketing growing very fast and so is the need for cartons boxes. - Company is run by a sole owner and has an bank overdraft facility of INR 30 lakh.

In-house developed e-commerce platform for all product categories. - 800+ sellers already onboarded. Three foreign countries tapped - 2 more in the pipeline. - Zero on-boarding fees for sellers. - Free marketing for all the sellers on the platform. - Flat commission rate (7%) with no hidden fees. - We also provide fulfillment through third parties for some sellers. The long-term plan is to have in-house logistics. - Our mission is to build a seller-focused marketplace for Indian brands and provide them access to global customers. - We envision empowering small, medium and large retailers by bringing them online. - Marketing is limited to Facebook, and SEO at the moment. - This is a debt-free entity. - The company has six shareholders, where five of them own 2%, 5%, 5%, 6%, 10% and the remaining 72 % is held by the majority shareholder. - The majority shareholder has 10 years of experience in the e-commerce industry.

We are a unique training academy providing placement opportunities. - Our USP is our skilled staff and promoters having loads of experience in the hospitality and aviation industries with personal relationships in these sectors. - Currently, we have 9 students enrolled with us. 5 students have completed the course and have already been hired. - The business has three partners with a 50%, 30%, and 20% stake distribution. - Company does not have any outstanding loans.

The company has pioneered the first blood-based cancer detection tests capable of identifying up to 30 common cancers. - We have consistently focused on innovative solutions for early-stage cancer detection to significantly reduce cancer-related deaths. - The company employs an ingenious approach that combines cutting-edge experimental tools with the latest advancements in deep learning methodologies. - With the global rise in cancer incidence, annual cancer deaths have also increased significantly. - Most cancers are diagnosed at late stages due to the absence of early clinical symptoms, leading to poor prognosis. - Early detection of cancer can reduce mortality by up to 70%, yet no current methods accurately detect cancer at early stages. - We have leveraged this opportunity by developing a groundbreaking blood test that detects 30 cancers in both males and females. - Our product integrates molecular mapping of the physiological state with a deep learning platform to identify cancer-specific molecular signatures. - The test is a novel, non-invasive blood-based screening method capable of detecting cancers and identifying the tissue of origin from the same sample. - The 30 cancers detected represent about 90% of new cancer cases each year. - Our test has achieved an unmatched accuracy of over 98% for early-stage cancer detection. - This advancement can significantly reduce the global cancer mortality burden. - The company is in the process of commercializing the test. - The promoter have over 40+ years of experience in the industry. - Licenses include CIN, SSM and GST. We have also applied for a USFDA. We have applied to the DCGI (Drugs Controller General of India) for market approval in India. We will launch operations post the DCGI approval. - Our target audience includes hospitals in India and Singapore. - Our R&D headquarters are in Haryana, with global headquarters in Singapore. - We also maintain an office in Singapore with dedicated staff.

Gold-standard research has established our product as an elite, unique breakthrough branded ingredient and finished goods that have been commercially tested and proven in the Australasian, US and UK marketplace. As a supplier to English Premier League football clubs, and high-performance sports organizations such as the US Military, our product is used in the services and elite sports to provide a proven, legal competitive advantage. We have an official New Zealand All Blacks, product and collaborate with sports supplement companies such as Healthspan Elite and Science in Sport. Aside from finished goods, we have the branded ingredient, backed by a volume of clinicals, making a high-growth potential product in the US and EU. With restrictions on health claims in the EU, our finished goods marketing strategy is focused on the US, where we entered the market in 2022 and seeing strong growth in our D2C channels. Our unique provenance story centers around NZ’s powerful climate, which produces an exceptional polyphenol-rich berry fruit unique to the region. With concentrations and combinations of bioactive not present in any other berry, our fruit is key to producing a high-quality, high-potency extract that delivers a host of antioxidant, vasodilatory, and anti-inflammatory actions. The product’s exceptional multiplicity of physiological properties has led to international brand recognition, with five Sports Nutrition Product Champion awards (Nutra Ingredients/ESSNA - Europe, USA, Asia), and three Best Recovery Product titles (UK, Europe). We have been shortlisted once again for the Champion Sports Nutrition Award in Europe this year. With our product name-checked in all published studies, our material and science are responsible for many of the major anthocyanin-derived breakthroughs of the last decade. Our current combined revenues are operating at approx USD 700,000 from our small business enterprises in the UK, NZ, and Australia. As the first-to-market New Zealand blackcurrant brand, the company’s primary focus is to capitalize on a decade of research investment and development. A well-supported sales and marketing strategy can leverage this rare offering with the right strategic partner.